Farms.com Home   News

Be Prepared: Transitioning Certain OTC Antimicrobial Products to Rx June 2023

FDA published Guidance for Industry (GFI) #263 in June 2021 which outlined a plan for transitioning certain over-the-counter (OTC) antimicrobial products for animals to prescription (Rx) status. As outlined in FDA's Guidance for Industry (GFI) #263, FDA expects approved animal drug products containing medically important antimicrobials that are currently available as OTC products to transition to Rx status beginning in June 2023. To help prepare for this transition, FDA Center for Veterinary Medicine (CVM) is conducting outreach to increase awareness about this expected change.

FDA CVM has developed written materials with information on products/indications that will be transitioning as part of GFI 263 and information on how interested animal owners can locate a vet. Also linked below are a brochure and poster which detail the importance of veterinary involvement as products transition to Rx.

Click here to see more...

Trending Video

Farm Health Guardian | Digital Biosecurity in Real Time

Video: Farm Health Guardian | Digital Biosecurity in Real Time

Disease risk, biosecurity, and real-time monitoring continue to be major topics across the pork industry. In this episode of Swine Web Industry Perspectives, presented by Farm Health Guardian, we discuss how digital biosecurity and real-time data are changing the way producers think about herd protection, people movement, and operational decision-making.

The conversation explores:

disease risk in modern pork production,

the impact of people movement on biosecurity,

the importance of real-time monitoring,

digital biosecurity technology,

and how Farm Health Guardian developed tools designed to support modern swine operations.

As the industry continues focusing on prevention, preparedness, and operational efficiency, connected technologies and actionable data are becoming increasingly important parts of modern herd health management.